1172 related articles for article (PubMed ID: 18048882)
1. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
[TBL] [Abstract][Full Text] [Related]
2. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.
Shumay DM; Maskarinec G; Kakai H; Gotay CC;
J Fam Pract; 2001 Dec; 50(12):1067. PubMed ID: 11742609
[TBL] [Abstract][Full Text] [Related]
3. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
4. Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients.
Tatsumura Y; Maskarinec G; Shumay DM; Kakai H
Altern Ther Health Med; 2003; 9(3):64-71. PubMed ID: 12776477
[TBL] [Abstract][Full Text] [Related]
5. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
6. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
7. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.
Tasaki K; Maskarinec G; Shumay DM; Tatsumura Y; Kakai H
Psychooncology; 2002; 11(3):212-20. PubMed ID: 12112481
[TBL] [Abstract][Full Text] [Related]
8. Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors.
Humpel N; Jones SC
Eur J Cancer Care (Engl); 2006 Sep; 15(4):362-8. PubMed ID: 16968318
[TBL] [Abstract][Full Text] [Related]
9. Complementary therapies for cancer patients: assessing information use and needs.
Verhoef MJ; Trojan L; Armitage GD; Carlson L; Hilsden RJ
Chronic Dis Can; 2009; 29(2):80-8. PubMed ID: 19281693
[TBL] [Abstract][Full Text] [Related]
10. What is an exceptional cancer trajectory?: Multiple stakeholder perspectives on cancer trajectories in relation to complementary and alternative medicine use.
Hök J; Forss A; Falkenberg T; Tishelman C
Integr Cancer Ther; 2009 Jun; 8(2):153-63. PubMed ID: 19679624
[TBL] [Abstract][Full Text] [Related]
11. The influence of significant others in complementary and alternative medicine decisions by cancer patients.
Ohlén J; Balneaves LG; Bottorff JL; Brazier AS
Soc Sci Med; 2006 Sep; 63(6):1625-36. PubMed ID: 16725245
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
[TBL] [Abstract][Full Text] [Related]
13. The use of complementary and alternative therapies by cancer patients in northern Israel.
Hana G; Bar-Sela G; Zhana D; Mashiach T; Robinson E
Isr Med Assoc J; 2005 Apr; 7(4):243-7. PubMed ID: 15847205
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
Can G; Erol O; Aydiner A; Topuz E
Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
[TBL] [Abstract][Full Text] [Related]
15. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Chrystal K; Allan S; Forgeson G; Isaacs R
N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
[TBL] [Abstract][Full Text] [Related]
16. Complementary and alternative medicine use in patients with haematological malignancies in Europe.
Molassiotis A; Margulies A; Fernandez-Ortega P; Pud D; Panteli V; Bruyns I; Scott JA; Gudmundsdottir G; Browall M; Madsen E; Ozden G; Magri M; Selvekerova S; Platin N; Kearney N; Patiraki E
Complement Ther Clin Pract; 2005 May; 11(2):105-10. PubMed ID: 15955292
[TBL] [Abstract][Full Text] [Related]
17. Taiwanese adult cancer patients' reports of using complementary therapies.
Lu JH; Tsay SL; Sung SC
Cancer Nurs; 2010; 33(4):320-6. PubMed ID: 20467307
[TBL] [Abstract][Full Text] [Related]
18. Alternative medicine or "alternative" patients: a qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine.
Caspi O; Koithan M; Criddle MW
Med Decis Making; 2004; 24(1):64-79. PubMed ID: 15005956
[TBL] [Abstract][Full Text] [Related]
19. Complementary and alternative medicine use in lung cancer patients in eight European countries.
Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
[TBL] [Abstract][Full Text] [Related]
20. Use of complementary and alternative medicine among cancer patients in Israel.
Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
